CA2277724C - Composition destinee a provoquer une anergie humorale a un immunogene - Google Patents

Composition destinee a provoquer une anergie humorale a un immunogene Download PDF

Info

Publication number
CA2277724C
CA2277724C CA002277724A CA2277724A CA2277724C CA 2277724 C CA2277724 C CA 2277724C CA 002277724 A CA002277724 A CA 002277724A CA 2277724 A CA2277724 A CA 2277724A CA 2277724 C CA2277724 C CA 2277724C
Authority
CA
Canada
Prior art keywords
immunogen
conjugate
cell
conjugate according
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002277724A
Other languages
English (en)
Other versions
CA2277724A1 (fr
Inventor
Paul Arylin Barstad
Gilbert Michael Iverson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Jolla Pharmaceutical Co
Original Assignee
La Jolla Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/652,648 external-priority patent/US5268454A/en
Application filed by La Jolla Pharmaceutical Co filed Critical La Jolla Pharmaceutical Co
Publication of CA2277724A1 publication Critical patent/CA2277724A1/fr
Application granted granted Critical
Publication of CA2277724C publication Critical patent/CA2277724C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002277724A 1991-02-08 1992-02-04 Composition destinee a provoquer une anergie humorale a un immunogene Expired - Fee Related CA2277724C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US652,648 1991-02-08
US07/652,648 US5268454A (en) 1991-02-08 1991-02-08 Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
CA002076648A CA2076648C (fr) 1991-02-08 1992-02-04 Composition destinee a provoquer une anergie humorale a un immunogene

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002076648A Division CA2076648C (fr) 1991-02-08 1992-02-04 Composition destinee a provoquer une anergie humorale a un immunogene

Publications (2)

Publication Number Publication Date
CA2277724A1 CA2277724A1 (fr) 1992-08-09
CA2277724C true CA2277724C (fr) 2003-05-27

Family

ID=25675458

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002277724A Expired - Fee Related CA2277724C (fr) 1991-02-08 1992-02-04 Composition destinee a provoquer une anergie humorale a un immunogene

Country Status (1)

Country Link
CA (1) CA2277724C (fr)

Also Published As

Publication number Publication date
CA2277724A1 (fr) 1992-08-09

Similar Documents

Publication Publication Date Title
CA2076648C (fr) Composition destinee a provoquer une anergie humorale a un immunogene
CA1340956C (fr) Peptides synthetiques representant un determinant antigenique de cellulet comme molecule porteuse de vaccins
EP0313651B1 (fr) Peptides synthetiques pour le diagnostic et la prevention d'infections par le virus influenza, et leur utilisation
SK11295A3 (en) Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
US6048529A (en) PVA or PEG conjugates of peptides for epitope-specific immunosuppression
Muckerheide et al. Immunosuppressive properties of a peptic fragment of BSA
GOODMAN Antigenic determinants and antibody combining sites
KR0134117B1 (ko) 성장 호르몬 펩티드를 포함하는 성장 호르몬의 활성을 상승시키기 위한 약학 제제, 이를 동물에게 투여하여 생물학적 특성을 변경시키는 방법
WO1991008220A1 (fr) Procede de synthese regulee par etapes d'especes chimiques, notamment de peptides, de produits couples obtenus selon le procede, et emploi de ces produits couples, par exemple en tant que vaccins
JPH10509038A (ja) 免疫、精製及び検出適用のためのたんぱく質、ペプチド及び複合物の高い水準の発現と容易な精製
Buchanan-Davidson et al. Immunochemistry of Synthetic Polypeptides and Polypeptidyl Proteins: III. Antigenicity of the Synthetic Polypeptides
CA2277724C (fr) Composition destinee a provoquer une anergie humorale a un immunogene
Atassi Immune recognition of serum albumin. 15: Localization by Synthesis of antigenic Site 4 of bovine serum albumin to theregion around the disulfide bond 166–175
AU629179B2 (en) Biologically active segments of several growth hormones
Coleman Protein haptenation by drugs.
KR930703444A (ko) 어류 황체화 호르몬-방출 호르몬 동족체
CA2028517A1 (fr) Stimulation de la somatotrophine porcine
WO1994000487A1 (fr) Peptide produisant une immunite protectrice contre le tetanos
Singh et al. IMMUNOGENIC DETERMINANTS OF INSULIN; SYNTHESIS AND IMMUNO-GENICITY OF THE A-CHAIN LOOP PEPTIDES OF BEEF INSULIN
WO2023022613A2 (fr) Immunoglobulines anti-peptidiques pour des épitopes de glycoprotéine de spicule de coronavirus de syndrome respiratoire aigu sévère 2 (sras-cov -2) et immunogènes apparentés, procédé de production et d'utilisation de ceux-ci, et systèmes de détection d'antigène associés à ceux-ci
Alsenz Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha...
MXPA00011938A (en) Peptide composition as immunogen for the treatment of allergy

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed